Last 12 months
Inside the activity.
0 purchase rows · 95 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 11 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 5,936 | $46.37 | $275,271.32 |
DisclosureSEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 4 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.20 to $47.17 per share, inclusive. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 8,364 | $45.89 | $383,816.43 |
DisclosureSEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 3 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,036 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.20 to $46.19 per share, inclusive. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 600 | $44.21 | $26,523.00 |
DisclosureSEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,400 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.15 to $44.29 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionCommon Stock | 15,000 | $10.42 | $156,300.00 |
DisclosureSEC source: 0002050172-26-000009 · form4-02042026_090238.xml · nonDerivative · entry 1 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:21 UTC |
Dandekar AtulCSBO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050167-26-000003 · form4-02022026_090232.xml · derivative · entry 5 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,643 Underlying: Common Stock · 7,500 shares Expires 2031-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:21 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 2,800 | $45.01 | $126,022.40 |
DisclosureSEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 4 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,503 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.54 to $45.53 per share, inclusive. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:21 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 3,500 | $44.04 | $154,146.65 |
DisclosureSEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 3 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,303 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.51 to $44.49 per share, inclusive. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:21 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 1,200 | $43.18 | $51,821.28 |
DisclosureSEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 2 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,803 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.49 to $43.46 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:21 UTC |
Dandekar AtulCSBO
|
Exercise / conversionCommon Stock | 7,500 | $10.42 | $78,150.00 |
DisclosureSEC source: 0002050167-26-000003 · form4-02022026_090232.xml · nonDerivative · entry 1 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 16:10 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,503 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-26-000005 · form4-01262026_090133.xml · derivative · entry 5 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,869 Underlying: Common Stock · 2,503 shares Expires 2032-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on March 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 16:10 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,497 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-26-000005 · form4-01262026_090133.xml · derivative · entry 4 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 486 Underlying: Common Stock · 2,497 shares Expires 2031-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 16:10 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 5,000 | $45.52 | $227,612.00 |
DisclosureSEC source: 0002050422-26-000005 · form4-01262026_090133.xml · nonDerivative · entry 3 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,965 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.93 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 16:10 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 2,503 | $10.42 | $26,081.26 |
DisclosureSEC source: 0002050422-26-000005 · form4-01262026_090133.xml · nonDerivative · entry 2 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 16:10 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 2,497 | $10.42 | $26,018.74 |
DisclosureSEC source: 0002050422-26-000005 · form4-01262026_090133.xml · nonDerivative · entry 1 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,281 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 10 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,805 Underlying: Common Stock · 3,281 shares Expires 2034-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,895 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 9 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316 Underlying: Common Stock · 2,895 shares Expires 2033-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,744 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 8 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,744 shares Expires 2031-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 2, 2024. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
SaleCommon Stock | 26,920 | $39.11 | $1,052,784.67 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 6 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.04 to $39.85 per share, inclusive. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionCommon Stock | 3,281 | $10.42 | $34,188.02 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 5 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionCommon Stock | 2,895 | $10.42 | $30,165.90 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 4 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionCommon Stock | 20,744 | $10.42 | $216,152.48 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 3 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:51 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,156 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-26-000006 · form4-01092026_090123.xml · derivative · entry 3 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,407 Underlying: Common Stock · 25,156 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:51 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 25,156 | $40.20 | $1,011,298.87 |
DisclosureSEC source: 0002050172-26-000006 · form4-01092026_090123.xml · nonDerivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.55 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:51 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionCommon Stock | 25,156 | $10.42 | $262,125.52 |
DisclosureSEC source: 0002050172-26-000006 · form4-01092026_090123.xml · nonDerivative · entry 1 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,493 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · derivative · entry 7 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,211 Underlying: Common Stock · 2,493 shares Expires 2033-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
SaleCommon Stock | 2,493 | $38.62 | $96,269.69 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 2 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.61 to $38.6225 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 2 of this Form 4. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:30 UTC |
Sohn Catherine A.Director
|
Exercise / conversionCommon Stock | 2,493 | $10.42 | $25,977.06 |
DisclosureSEC source: 0001555132-26-000006 · form4-01082026_090134.xml · nonDerivative · entry 1 Sohn Catherine A. · CIK 0001555132 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:31 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 412 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-26-000003 · form4-01062026_090146.xml · derivative · entry 6 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 337,563 Underlying: Common Stock · 412 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:31 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 412 | $40.00 | $16,480.00 |
DisclosureSEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 4 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:31 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionCommon Stock | 412 | $10.42 | $4,293.04 |
DisclosureSEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 3 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:30 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,796 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-26-000003 · form4-01062026_090124.xml · derivative · entry 6 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,983 Underlying: Common Stock · 4,796 shares Expires 2031-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 1, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:30 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 204 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-26-000003 · form4-01062026_090124.xml · derivative · entry 5 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,377 Underlying: Common Stock · 204 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on November 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:30 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 2,595 | $39.57 | $102,681.30 |
DisclosureSEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 4 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,965 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.15 to $39.99 per share, inclusive. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:30 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 2,405 | $38.70 | $93,072.30 |
DisclosureSEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 3 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,560 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.15 to $39.14 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:30 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 4,796 | $10.42 | $49,974.32 |
DisclosureSEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 2 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:30 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 204 | $10.42 | $2,125.68 |
DisclosureSEC source: 0002050422-26-000003 · form4-01062026_090124.xml · nonDerivative · entry 1 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:31 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,432 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-26-000003 · form4-01062026_090146.xml · derivative · entry 5 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 337,975 Underlying: Common Stock · 4,432 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:31 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 4,432 | $40.43 | $179,187.53 |
DisclosureSEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.965 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:31 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionCommon Stock | 4,432 | $10.42 | $46,181.44 |
DisclosureSEC source: 0002050172-26-000003 · form4-01062026_090146.xml · nonDerivative · entry 1 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 16:20 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,605 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-25-000007 · form4-12312025_091203.xml · derivative · entry 11 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,581 Underlying: Common Stock · 2,605 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F7 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on November 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 16:20 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,395 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050422-25-000007 · form4-12312025_091203.xml · derivative · entry 10 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1 Underlying: Common Stock · 2,395 shares Expires 2031-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 1, 2025. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 16:20 UTC |
Bachrodt AmySVP, Finance
|
SaleCommon Stock | 5,000 | $40.08 | $200,407.00 |
DisclosureSEC source: 0002050422-25-000007 · form4-12312025_091203.xml · nonDerivative · entry 7 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,965 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.36 per share, inclusive. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 16:20 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 2,605 | $10.42 | $27,144.10 |
DisclosureSEC source: 0002050422-25-000007 · form4-12312025_091203.xml · nonDerivative · entry 6 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 16:20 UTC |
Bachrodt AmySVP, Finance
|
Exercise / conversionCommon Stock | 2,395 | $10.42 | $24,955.90 |
DisclosureSEC source: 0002050422-25-000007 · form4-12312025_091203.xml · nonDerivative · entry 5 Bachrodt Amy · CIK 0002050422 · SVP, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 21:24 UTC |
Dandekar AtulCSBO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050167-25-000007 · form4-12312025_091220.xml · derivative · entry 7 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,143 Underlying: Common Stock · 100 shares Expires 2031-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F5 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 21:24 UTC |
Dandekar AtulCSBO
|
SaleCommon Stock | 100 | $40.36 | $4,036.00 |
DisclosureSEC source: 0002050167-25-000007 · form4-12312025_091220.xml · nonDerivative · entry 5 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,503 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 21:24 UTC |
Dandekar AtulCSBO
|
Exercise / conversionCommon Stock | 100 | $10.42 | $1,042.00 |
DisclosureSEC source: 0002050167-25-000007 · form4-12312025_091220.xml · nonDerivative · entry 4 Dandekar Atul · CIK 0002050167 · CSBO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. Read SEC document |
| December 29, 2025 Filed Dec 31, 2025 21:22 UTC |
Bernstein HaroldPresident, R&D & CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $10.42 | $0.00 |
DisclosureSEC source: 0002050172-25-000007 · form4-12312025_091232.xml · derivative · entry 4 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 342,407 Underlying: Common Stock · 45,000 shares Expires 2032-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F4 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| December 29, 2025 Filed Dec 31, 2025 21:22 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 17,200 | $40.93 | $703,930.64 |
DisclosureSEC source: 0002050172-25-000007 · form4-12312025_091232.xml · nonDerivative · entry 3 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.51 per share, inclusive. Read SEC document |
| December 29, 2025 Filed Dec 31, 2025 21:22 UTC |
Bernstein HaroldPresident, R&D & CMO
|
SaleCommon Stock | 27,800 | $40.34 | $1,121,424.20 |
DisclosureSEC source: 0002050172-25-000007 · form4-12312025_091232.xml · nonDerivative · entry 2 Bernstein Harold · CIK 0002050172 · President, R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,200 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.71 to $40.705 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.